Allograft glomerulitis: histologic characteristics to detect chronic humoral rejection.
The aim of this study was to clarify the histopathologic significance of allograft glomerulitis in chronic allograft nephropathy (CAN). Review of our renal allograft biopsy files revealed 140 specimens with CAN among 115 selected patients. They were classified into two groups: one had CAN with glomerulitis (group G), and the other was free of this finding (group NG). We evaluated the clinicopathologic parameters as follows: levels of serum creatinine and proteinuria in the biopsy; presence of circulating anti-donor antibodies; allograft failure rate; history of biopsy-proven acute cellular rejection (ACR) and acute humoral rejection (AHR); complications of ACR and chronic rejection (CR); and results of immunofluorescence studies for C4d and HLA-DR. The glomerulitis group showed a significantly greater incidence of CR complications, the presence of circulating anti-donor antibodies, and C4d deposition in peritubular and glomerular capillaries. This group also showed higher levels of serum creatinine and proteinuria, higher graft loss rate, and increased AHR incidence, although the differences were not significant. There was also no statistical significance in the HLA-DR expression on tubular epithelial cells. The present results strongly suggest that humoral factors may play an important role in the progression of glomerulitis in CAN. Therefore, we suspect that glomerulitis in CAN is one of the main histologic markers for CR. The presence of glomerulitis may represent humoral factor-dependent inflammation. It should be considered an important diagnostic criterion for CR in addition to double-contour formation and elastica disruptions with or without subendothelial inflammation (Banff '97).
Hara
S
S
Department of Pathology, Toranomon Hospital, Tokyo, Japan.
Matsushita
H
H
Yamaguchi
Y
Y
Kawaminami
K
K
Horita
S
S
Furusawa
M
M
D000017:ABO Blood-Group System; D000293:Adolescent; D000328:Adult; D000368:Aged; D000917:Antibody Formation; D001787:Blood Group Incompatibility; D002102:Cadaver; D002648:Child; D003404:Creatinine / Q000097:blood; D005260:Female; D005921:Glomerulonephritis / Q000473:pathology*; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000473:pathology; D012189:Retrospective Studies; D014019:Tissue Donors; D014184:Transplantation, Homologous / Q000473:pathology*; D017211:Treatment Failure
D000017:ABO Blood-Group System; D007518:Isoantibodies; D003404:Creatinine